1005009-98-2Relevant articles and documents
HETEROARYL COMPOUNDS AND USES THEREOF
-
Paragraph 0116-0118, (2019/11/28)
Described herein are compounds of formula (I), and pharmaceutically acceptable salts, solvates, hydrates, isotopically labeled derivatives and radiolabeled derivative thereof, and pharmaceutical compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for detecting and imaging Tau aggregates in the brain for detection of Alzheimer's disease (AD) in a subject.
SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS
-
Page/Page column 35, (2013/02/27)
Provided are certain pyridopyrazine compounds, pharmaceutical compositions thereof and methods of use therefor.
2,4-SUBSTITUTED QUINAZOLINES AS LIPID KINASE INHIBITORS
-
Page/Page column 70, (2008/06/13)
The invention relates to compounds of the formula (I), which are appropriate for the treatment of kinase, e.g. PI3K-related, diseases, such as proliferative diseases, inflammatory diseases, obstructive airways disorders and transplantation related disease